Teva Announces FDA Approval of Ajovy (fremanezumab-vfrm) Injection Autoinjector

PARSIPPANY, N.J.–(BUSINESS WIRE) January 28, 2020 — Teva Pharmaceuticals USA, Inc. an affiliate ofTeva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the Food and Drug Administration (FDA) has approved an autoinjector device for Ajovy® (fremanezumab-vfrm) injection. “The approval of the Ajovy autoinjector is another important step forward for Teva and the migraine community,” said Brendan O’Grady, executive […]

Read more

Medicaid expansion associated with fewer opioid overdose deaths across the US

The expansion of Medicaid coverage for low-income adults permitted by the Affordable Care Act (ACA) was associated with a six percent reduction in total opioid overdose deaths nationally, according to new research from NYU Grossman School of Medicine and University of California, Davis. Published online January 10 in JAMA Network Open, the study is the first to look at whether […]

Read more

Study urges life-saving drug treatment to combat Ukraine’s HIV epidemic

Credit: Michael S. Helfenbein University researchers finds that scaling up use of methadone and buprenorphine—medications for treating opioid use disorder known as opioid agonist therapies (OATs)—could greatly reduce HIV transmission rates and prevent deaths in Ukraine, where the disease is epidemic among people who inject drugs. The study was published in The Lancet. Annual new HIV infections in Ukraine—home to […]

Read more

Out-of-pocket costs for Medicare recipients will rise in new year

(HealthDay)—Seniors on Medicare are going to take a hit to the pocketbook in 2020, with premiums and deductibles set to increase on coverage for medical services and prescription drugs. The standard monthly premium for Medicare Part B will rise $9.10, to $144 a month, the U.S. Centers for Medicare and Medicaid Services (CMS) announced. The annual deductible for Part B […]

Read more

Women with a low desire to avoid pregnancy still use contraception

A new study from the University of California San Francisco (UCSF) and Columbia University Mailman School of Public Health challenges assumptions that women with the highest preference against pregnancy use more effective contraceptive methods and that women who might welcome pregnancy do not use contraception. Overall, women with a stronger preference to avoid pregnancy were far more likely to use […]

Read more

Is ivermectin safe during pregnancy?

Is it safe to give ivermectin to pregnant women? In order to answer this question, researchers from the Barcelona Institute for Global Health (ISGlobal), an institution supported by “la Caixa,” conducted a systematic review and meta-analysis of studies that reported cases of accidental exposure to the drug among pregnant women. The conclusion of the analysis, published in The Lancet Global […]

Read more

Prescribers be aware of fatal risks of methadone and clozapine

New Zealand prescribers should be aware of the high risk of death associated with two prescription medicines, methadone and clozapine, University of Otago researchers warn. In the largest review of medicine-related deaths in the National Coronial Information System between 1 January 2008 to 31 December 2013, Dr. John Fountain and his colleagues from the Dunedin School of Medicine and Best […]

Read more

New cancer inhibitor effective where others fail

A novel agent called Selinexor has opened up new options for the treatment of patients with refractory myeloma. This was the conclusion of a major international clinical trial in which also the Karl Landsteiner University of Health Sciences in Krems, Austria (KL Krems) participated. The results have now been published in the New England Journal of Medicine. Thanks to a […]

Read more
1 2 3 10